Fresenius

fresenius-kabi.com

Fresenius Kabi Austria GmbH

Hafnerstrasse 36
8055 Graz
Austria

Phone

fresenius-kabi.com
Contact
Profile Products News

About Fresenius

Fresenius Kabi in Austria specializes in products for infusion and nutrition therapy. We develop, produce and distribute a full portfolio of IV drugs and nutrition products, and with these product groups we are one of the leading companies in the Austrian hospital and homecare sectors.

Read more about Fresenius

Advertisement

Revolutionize your production: real-time Raman analysis for maximum efficiency
Revolutionize your production: real-time Raman analysis for maximum efficiency
Efficient inline analysis for liquids and solids
Efficient inline analysis for liquids and solids
User-friendly software for effortless Design of Experiments (DoE)
User-friendly software for effortless Design of Experiments (DoE)

Product portfolio of Fresenius

Product portfolio

Show all

News about Fresenius

Fresenius

25-Apr-2017 | business & finance

Merck Divests Biosimilars Business to Fresenius

Merck announced the divestment of its Biosimilars business to Fresenius. The decision to divest Biosimilars is aligned with Merck’s strategy for its ...

Read news
Fresenius

31-Jan-2011 | business & finance

Swedish Orphan Biovitrum agrees with Fresenius Biotech to distribute Removab

Swedish Orphan Biovitrum announced a Removab® distribution agreement with Fresenius Biotech. Under the agreement Swedish Orphan Biovitrum (Sobi) will ...

Read news
Fresenius

29-Oct-2010 | research and development

Trifunctional antibody Removab from Fresenius Biotech awarded Galenus von Pergamon Prize for drug innovation

The trifunctional antibody Removab® (Catumaxomab) from Fresenius Biotech was awarded this year’s Galenus von Pergamon Prize in the “Specialist Care” ...

Read news
Fresenius

15-Jan-2010 | business & finance

Fresenius Kabi and Bayer Schering Pharma extend collaboration regarding HESylation Technology

Fresenius Kabi Deutschland GmbH and Bayer Schering Pharma AG have extended their collaboration in the field of HESylation® Technology. The companies ...

Read news
Fresenius

30-Oct-2009 | business & finance

Fresenius Kabi and Octapharma Group enter into an Exclusive Agreement for a HESylated recombinant protein

Fresenius Kabi and Octapharma Group have signed a License, Development and Supply Agreement regarding the use of Fresenius Kabi’s HESylation® Technology to ...

Read news
Fresenius

09-Jun-2009 | business & finance

BioNTech AG acquires EUFETS AG

BioNTech AG announced the acquisition of all shares of EUFETS AG from Fresenius Biotech GmbH (Munich, Germany). EUFETS, formerly a fully owned subsidiary ...

Read news
Fresenius

04-Jun-2009 | business & finance

Fresenius Kabi and Bayer Schering Pharma enter into a Research, Development and License Agreement

Fresenius Kabi Deutschland GmbH and Bayer Schering Pharma AG have signed a Research, Development and License Agreement regarding the use of Fresenius Kabi ...

Read news
Fresenius

27-Apr-2009 | research and development

Removab Approval: Proof-of-Concept for Technology Transfer in Germany

The European Commission has granted approval for the trifunctional anti-cancer antibody Removab®. It is the first approved therapeutic antibody originating ...

Read news
Show more news about Fresenius

Here you will find Fresenius Kabi Austria GmbH